Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect

Aminopeptidase A (APA) cleaves angiotensin (Ang) II, kallidin, and other related peptides. In the brain, it activates the renin angiotensin system and causes hypertension. Limited data are available on the dipsogenic effect of APA and pressor effect of degraded peptides of APA such as bradykinin. Wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Takuto Nakamura, Masanobu Yamazato, Akio Ishida, Yusuke Ohya
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2017/3967595
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549797337235456
author Takuto Nakamura
Masanobu Yamazato
Akio Ishida
Yusuke Ohya
author_facet Takuto Nakamura
Masanobu Yamazato
Akio Ishida
Yusuke Ohya
author_sort Takuto Nakamura
collection DOAJ
description Aminopeptidase A (APA) cleaves angiotensin (Ang) II, kallidin, and other related peptides. In the brain, it activates the renin angiotensin system and causes hypertension. Limited data are available on the dipsogenic effect of APA and pressor effect of degraded peptides of APA such as bradykinin. Wistar-Kyoto rats received intracerebroventricular (icv) APA in a conscious, unrestrained state after pretreatment with (i) vehicle, (ii) 80 μg of telmisartan, an Ang II type-1 (AT1) receptor blocker, (iii) 800 nmol of amastatin, an aminopeptidase inhibitor, and (iv) 1 nmol of HOE-140, a bradykinin B2 receptor blocker. Icv administration of 400 and 800 ng of APA increased blood pressure by 12.6 ± 3.0 and 19.0 ± 3.1 mmHg, respectively. APA did not evoke drinking behavior. Pressor response to APA was attenuated on pretreatment with telmisartan (vehicle: 22.1 ± 2.2 mmHg versus telmisartan: 10.4 ± 3.2 mmHg). Pressor response to APA was also attenuated with amastatin and HOE-140 (vehicle: 26.5 ± 1.1 mmHg, amastatin: 14.4 ± 4.2 mmHg, HOE-140: 16.4 ± 2.2 mmHg). In conclusion, APA increase in the brain evokes a pressor response via enzymatic activity without dipsogenic effect. AT1 receptors and B2 receptors in the brain may contribute to the APA-induced pressor response.
format Article
id doaj-art-6299800328514e5299658d9d191bd9f0
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-6299800328514e5299658d9d191bd9f02025-02-03T06:08:37ZengWileyInternational Journal of Hypertension2090-03842090-03922017-01-01201710.1155/2017/39675953967595Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic EffectTakuto Nakamura0Masanobu Yamazato1Akio Ishida2Yusuke Ohya3Department of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa Prefecture, JapanDepartment of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa Prefecture, JapanDepartment of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa Prefecture, JapanDepartment of Cardiovascular Medicine, Nephrology and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa Prefecture, JapanAminopeptidase A (APA) cleaves angiotensin (Ang) II, kallidin, and other related peptides. In the brain, it activates the renin angiotensin system and causes hypertension. Limited data are available on the dipsogenic effect of APA and pressor effect of degraded peptides of APA such as bradykinin. Wistar-Kyoto rats received intracerebroventricular (icv) APA in a conscious, unrestrained state after pretreatment with (i) vehicle, (ii) 80 μg of telmisartan, an Ang II type-1 (AT1) receptor blocker, (iii) 800 nmol of amastatin, an aminopeptidase inhibitor, and (iv) 1 nmol of HOE-140, a bradykinin B2 receptor blocker. Icv administration of 400 and 800 ng of APA increased blood pressure by 12.6 ± 3.0 and 19.0 ± 3.1 mmHg, respectively. APA did not evoke drinking behavior. Pressor response to APA was attenuated on pretreatment with telmisartan (vehicle: 22.1 ± 2.2 mmHg versus telmisartan: 10.4 ± 3.2 mmHg). Pressor response to APA was also attenuated with amastatin and HOE-140 (vehicle: 26.5 ± 1.1 mmHg, amastatin: 14.4 ± 4.2 mmHg, HOE-140: 16.4 ± 2.2 mmHg). In conclusion, APA increase in the brain evokes a pressor response via enzymatic activity without dipsogenic effect. AT1 receptors and B2 receptors in the brain may contribute to the APA-induced pressor response.http://dx.doi.org/10.1155/2017/3967595
spellingShingle Takuto Nakamura
Masanobu Yamazato
Akio Ishida
Yusuke Ohya
Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
International Journal of Hypertension
title Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
title_full Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
title_fullStr Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
title_full_unstemmed Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
title_short Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect
title_sort excess of aminopeptidase a in the brain elevates blood pressure via the angiotensin ii type 1 and bradykinin b2 receptors without dipsogenic effect
url http://dx.doi.org/10.1155/2017/3967595
work_keys_str_mv AT takutonakamura excessofaminopeptidaseainthebrainelevatesbloodpressureviatheangiotensiniitype1andbradykininb2receptorswithoutdipsogeniceffect
AT masanobuyamazato excessofaminopeptidaseainthebrainelevatesbloodpressureviatheangiotensiniitype1andbradykininb2receptorswithoutdipsogeniceffect
AT akioishida excessofaminopeptidaseainthebrainelevatesbloodpressureviatheangiotensiniitype1andbradykininb2receptorswithoutdipsogeniceffect
AT yusukeohya excessofaminopeptidaseainthebrainelevatesbloodpressureviatheangiotensiniitype1andbradykininb2receptorswithoutdipsogeniceffect